Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-014556
Filing Date
2013-03-06
Accepted
2013-03-06 16:36:01
Documents
1
Period of Report
2013-03-04

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c496931_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c496931_4x0.xml 4 3200
  Complete submission text file 0001209191-13-014556.txt   4689
Mailing Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080
Business Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080 650-780-4777
SOLAZYME INC (Issuer) CIK: 0001311230 (see all company filings)

EIN.: 331077078 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals

Mailing Address 340 Madison Ave New York NY 10017
Business Address 340 Madison Ave New York NY 10017 212-697-0900
Braemar Energy Ventures II, LP (Reporting) CIK: 0001410447 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-35189 | Film No.: 13669989